1例II型糖尿病患者合并血栓性血小板减少性紫癜的护理
Nursing Care of a Patient with Type II Diabetes Complicated with Thrombotic Thrombocytopenic Purpura
DOI: 10.12677/ns.2025.143047, PDF,   
作者: 林 静：温州医科大学附属第二医院，浙江 温州；温州医科大学口腔医学院·附属口腔医院，浙江 温州；滕晓琼：浙江中医药大学附属温州市中医院，浙江 温州；彭 静：重庆市精神卫生中心护理部，重庆；张晨馨, 郭君怡*：温州医科大学口腔医学院·附属口腔医院，浙江 温州
关键词: 血栓性血小板减少性紫癜；II型糖尿病；血浆置换；护理；Thrombotic Thrombocytopenic Purpura； Type 2 Diabetes Mellitus； Plasma Exchange； Nursing
摘要: 目的：总结一例64岁II型糖尿病合并血栓性血小板减少性紫癜患者在院治疗调控血糖期间针对在血浆置换治疗过程中出现感染、内分泌代谢紊乱、出血、气体交换障碍等主要护理问题的护理要点，以期为相似案例提供借鉴。方法：就患者治疗全周期进行管理，以抢救生命、治疗疾病为重点，期间以控制管理基础疾病为基础，包括预防感染、血糖管理、症状护理、血浆置换护理、管道管理、心理护理等方面。结果：连续治疗10 d后患者生命体征暂时能够平稳，病情得到控制。结论：对患者生命治疗周期进行整体管控护理，针对基础慢性疾病合并疑难急症进行科学合理地护理，能迅速保障患者生命安全、提升治疗效率。
Abstract: Objective: To summarize the key points of nursing for a 64-year-old patient with type II diabetes mellitus complicated with thrombotic thrombocytopenic purpura during inpatient treatment for major nursing problems such as infection, endocrine and metabolic disorders, bleeding and gas exchange disorders during plasma exchange treatment, in order to provide reference for similar cases. Methods: The whole cycle of treatment was managed, focusing on life-saving and disease treatment, and the control and management of underlying diseases were the basis, including infection prevention, blood glucose management, symptom nursing, plasmapheresis nursing, pipeline management, and psychological nursing. Results: After 10 days of continuous treatment, the patient’s vital signs were temporarily stable and the condition was controlled. Conclusion: The overall control and nursing of the patient’s life cycle and the scientific and reasonable nursing for the underlying chronic diseases combined with intractable and urgent diseases can quickly ensure the life safety of patients and improve the treatment efficiency.
文章引用：林静, 滕晓琼, 彭静, 张晨馨, 郭君怡. 1例II型糖尿病患者合并血栓性血小板减少性紫癜的护理[J]. 护理学, 2025, 14(3): 344-349. https://doi.org/10.12677/ns.2025.143047

参考文献

[1] Alvarez-Larrán, A., del Río-Garma, J., Pujol, M., de la Rubia, J., Hernández-Jodra, M., Borrell, M., et al. (2009) Newly Diagnosed versus Relapsed Idiopathic Thrombotic Thrombocytopenic Purpura: A Comparison of Presenting Clinical Characteristics and Response to Treatment. Annals of Hematology, 88, 973-978. [Google Scholar] [CrossRef] [PubMed]
[2] 袁芬, 陈建军, 雷平, 等. 血栓性血小板减少性紫癜患者预后与疗效分析[J]. 中国实验血液学杂志, 2023, 31(5): 1448-1454.
[3] 王凌宇, 沈卫章, 谈磊, 等. 免疫性血栓性血小板减少性紫癜1例报告及文献复习[J]. 吉林大学学报(医学版), 2024, 50(6): 1734-1740.
[4] Qintai, F., Ying, H. and Yan, X. (2021) Nursing of a Severe Novel Bunyavirus Patient with Secondary Thrombotic Thrombocytopenic Purpura. Modern Clinical Nursing, 20, 83-86.
[5] 韩悦, 戚嘉乾. 血栓性血小板减少性紫癜诊治进展[J]. 临床血液学杂志, 2024, 37(7): 462-467.
[6] Knoebl, P., Cataland, S., Peyvandi, F., Coppo, P., Scully, M., Kremer Hovinga, J.A., et al. (2020) Efficacy and Safety of Open‐Label Caplacizumab in Patients with Exacerbations of Acquired Thrombotic Thrombocytopenic Purpura in the HERCULES Study. Journal of Thrombosis and Haemostasis, 18, 479-484. [Google Scholar] [CrossRef] [PubMed]
[7] Ziegler, M.C., Garbim Junior, E.E., Jahnke, V.S., Lisbôa Moura, J.G., Brasil, C.S., Schimitt da Cunha, P.H., et al. (2022) Impact of Probiotic Supplementation in a Patient with Type 2 Diabetes on Glycemic and Lipid Profile. Clinical Nutrition ESPEN, 49, 264-269. [Google Scholar] [CrossRef] [PubMed]
[8] 周赛君, 赵建彤, 叶翠, 等. 自然杀伤细胞与2型糖尿病[J]. 国际内分泌代谢杂志, 2017, 37(4): 274-276, 280.
[9] Daryabor, G., Atashzar, M.R., Kabelitz, D., Meri, S. and Kalantar, K. (2020) The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System. Frontiers in Immunology, 11, Article No. 1582. [Google Scholar] [CrossRef] [PubMed]
[10] 刘婉莹, 肖毅. 获得性血栓性血小板减少性紫癜的诊治进展[J]. 中国实用内科杂志, 2021, 41(10): 895-898+905.
[11] 吴积宝, 贺玉磊, 易继平, 等. 利妥昔单抗治疗难治性血栓性血小板减少性紫癜相关脑梗死1例报道及文献复习[J]. 卒中与神经疾病, 2024, 31(1): 87-89.
[12] Scully, M., Cataland, S.R., Peyvandi, F., Coppo, P., Knöbl, P., Kremer Hovinga, J.A., et al. (2019) Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura. New England Journal of Medicine, 380, 335-346. [Google Scholar] [CrossRef] [PubMed]
[13] Liu, Q., Lu, Z., Wang, X., et al. (2020) Application Value of Serum D-Dimer in Early Kidney Injury in Patients with Type 2 Diabetes. Journal of Modern Laboratory Medicine, 35, 134-138.
[14] Alwan, F., Vendramin, C., Vanhoorelbeke, K., Langley, K., McDonald, V., Austin, S., et al. (2017) Presenting ADAMTS13 Antibody and Antigen Levels Predict Prognosis in Immune-Mediated Thrombotic Thrombocytopenic Purpura. Blood, 130, 466-471. [Google Scholar] [CrossRef] [PubMed]
[15] 赵丽东, 王梅芳, 陈玙, 等. 血栓性血小板减少性紫癜发病机制及诊疗进展[J]. 临床血液学杂志, 2018, 31(11): 891-894.

为你推荐